.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Momenta is stocked at 101 licensed dispensaries across Pennsylvania, Maryland, and West Virginia, 58 of them in Pennsylvania, with the deepest coverage in Philadelphia, Pittsburgh, Lancaster, Montgomeryville, and Reading. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Momenta operated as a single-category brand in July 2026 with Concentrates at 100.0% mix, posting year-over-year sales growth of 19.5% alongside month-over-month expansion of 10.3%. Pricing moved counter to sales momentum, with an average price of $41.52 tied to a 8.7% YoY decline while unit growth outpaced value growth; within Concentrates specifically, the same 19.5% YoY and 10.3% MoM indicate category-led gains rather than portfolio reallocation. The brand held a rank of 30 in Concentrates in Maryland, and its top-state concentration in Maryland combined with 100.0% category focus implies execution is concentrated where depth in one segment can lift rank without cross-category dilution.
The July 2026 mix and price shifts point to a volume-led positioning in Concentrates: a 19.5% YoY sales lift paired with an 8.7% YoY price decrease suggests elastic demand capture, while a 10.3% MoM rise indicates near-term velocity rather than one-off distribution changes. Holding the 30 rank in Maryland Concentrates while pricing below last year positions Momenta to trade for share among price-sensitive shoppers, and the 100.0% single-category exposure means future rank movement will be disproportionately driven by unit velocity and pricing architecture within Concentrates rather than diversification. The implication is that maintaining MoM momentum while moderating further price erosion could convert July’s volume gains into sustained rank improvement in Maryland without relying on category expansion.
Competitive Landscape
Momenta sits at rank #30 in MD Concentrates in July 2026, down 5 positions year over year from #25 and 2 positions versus April 2026’s #32, while its peak rank of #25 in July 2025 marks a 5-position slide since that high; in contrast, District Cannabis held #1 year over year with 58.1% YoY sales growth and Grassroots advanced from #4 to #2 alongside 48.5% YoY growth. This divergence—Momenta’s rank declining 5 spots YoY as leaders either held or improved ranks by 1–2 positions—implies that without a mix shift or pricing/assortment reset, Momenta is being displaced from consideration in a category where leaderboard mobility is positive at the top and negative in the lower third.
Notable Products
The steepest movement in July 2026 is the collapse of Kush Lato RSO Syringe (1g), down 87.0% month over month while sitting at rank 7, paired with concurrent declines of 57.4% for Member Berry RSO Syringe (1g) at rank 6 and 52.7% for Ripped Off Runtz RSO Syringe (1g) at rank 5. Offsetting that downside, Thunder Punch RSO Syringe (1g) surged 241.7% MoM to rank 3 and Colonial Kush RSO Syringe (1g) jumped 135.9% MoM to rank 2, while W99 RSO Syringe (1g) held rank 1 with an 11.4% lift and approximately $5,135 in sales. With all top ten SKUs concentrated in the Concentrates/RSO Syringe family, the pattern implies Momenta is consolidating demand into a narrower set of breakout RSO strains while de-emphasizing underperforming variants.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
